Marta Alonso Guervós

Summary

Affiliation: Hospital Universitario
Country: Spain

Publications

  1. ncbi request reprint Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx and pharynx carcinomas
    Marta Alonso Guervós
    Department of Otolaryngology, Hospital Universitario Central de Asturias, Instituto Universitario de Oncologia del Principado de Asturias IUOPA, Oviedo, Spain
    Cell Oncol 29:327-34. 2007
  2. doi request reprint Genetic differences between primary larynx and pharynx carcinomas and their matched lymph node metastases by multiplex ligation-dependent probe amplification
    Marta Alonso Guervós
    Department of Otorhinolaryngology, IUOPA, Hospital Universitario Central de Asturias, Celestino Villamil s n, 33006 Oviedo, Asturias, Spain
    Oral Oncol 45:600-4. 2009
  3. doi request reprint Genetic profile of second primary tumors and recurrences in head and neck squamous cell carcinomas
    Virginia Franco Gutiérrez
    Department of Otorhinolaryngology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
    Head Neck 34:830-9. 2012
  4. doi request reprint The usefulness of new serum tumor markers in head and neck squamous cell carcinoma
    Cesar Alvarez Marcos
    Department of Otorhinolaryngology, Hospital Valle del Nalón Langreo, Oviedo, Spain
    Otolaryngol Head Neck Surg 140:375-80. 2009
  5. ncbi request reprint Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma
    Mario Hermsen
    Department of Otolaryngology, IUOPA, Hospital Universitario Central de Asturias, Oviedo, Spain
    Cell Oncol 27:191-8. 2005

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx and pharynx carcinomas
    Marta Alonso Guervós
    Department of Otolaryngology, Hospital Universitario Central de Asturias, Instituto Universitario de Oncologia del Principado de Asturias IUOPA, Oviedo, Spain
    Cell Oncol 29:327-34. 2007
    ..The aim of this study was to search such markers by using Multiplex Ligation-dependent Probe Amplification (MLPA), a semi-quantitative PCR technique to detect gene copy number alterations...
  2. doi request reprint Genetic differences between primary larynx and pharynx carcinomas and their matched lymph node metastases by multiplex ligation-dependent probe amplification
    Marta Alonso Guervós
    Department of Otorhinolaryngology, IUOPA, Hospital Universitario Central de Asturias, Celestino Villamil s n, 33006 Oviedo, Asturias, Spain
    Oral Oncol 45:600-4. 2009
    ..However, the lymph node metastases presented with a number of additional alterations. Acquisition of these alterations may play a role in lymphatic metastasis development...
  3. doi request reprint Genetic profile of second primary tumors and recurrences in head and neck squamous cell carcinomas
    Virginia Franco Gutiérrez
    Department of Otorhinolaryngology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
    Head Neck 34:830-9. 2012
    ..The purpose of this study was to determine the genetic changes in tumor samples to improve knowledge of tumor progression...
  4. doi request reprint The usefulness of new serum tumor markers in head and neck squamous cell carcinoma
    Cesar Alvarez Marcos
    Department of Otorhinolaryngology, Hospital Valle del Nalón Langreo, Oviedo, Spain
    Otolaryngol Head Neck Surg 140:375-80. 2009
    ..To determine the usefulness of specific and reliable serum biomarkers to predict cervical lymph node metastasis...
  5. ncbi request reprint Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma
    Mario Hermsen
    Department of Otolaryngology, IUOPA, Hospital Universitario Central de Asturias, Oviedo, Spain
    Cell Oncol 27:191-8. 2005
    ..These results seem to indicate that genetic alterations at the level of chromosomes have limited prognostic value in patients with invasive larynx and pharynx squamous cell carcinomas...